EichorEICHOR
Study identifier: NCT04988295 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

Condition: Carcinoma, Non-Small-Cell Lung  ·  Sponsor: Janssen Research & Development, LLC

PhasePhase 3
Planned participants776
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to assess the efficacy of adding lazertinib to amivantamab, carboplatin, and pemetrexed (LACP/ACP-L dosing strategies) and amivantamab, carboplatin and pemetrexed (ACP) compared with carboplatin and pemetrexed (CP) in participants with locally advanced or metastatic epidermal growth factor receptor (EGFR) Exon 19del or Exon 21 L858R substitution non-small cell lung cancer (NSCLC) after osimertinib failure. The purpose of the extension cohort is to further describe the safety and efficacy for the ACP-L dosing schedule versus ACP with additional data. After completion of the primary analysis, the study may eventually transition to an open-label extension (OLE) or long-term extension (LTE) phase during which participants will have the option to continue their assigned treatment.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (249)

Southern Cancer Center, PCMobile, Alabama, United States
Arizona Oncology AssociatesTucson, Arizona, United States
City of HopeDuarte, California, United States
Cedars Sinai Medical CenterLos Angeles, California, United States
University of California IrvineOrange, California, United States
Rocky Mountain Cancer CentersColorado Springs, Colorado, United States
Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer CenterFort Lauderdale, Florida, United States
University Cancer And Blood Center LLCAthens, Georgia, United States
University of Mississippi Medical CenterJackson, Mississippi, United States
Nebraska Cancer SpecialistsGrand Island, Nebraska, United States
Astera Cancer CareEast Brunswick, New Jersey, United States
TriHealth NetworkCincinnati, Ohio, United States

+ 237 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →